altRX vs Nurx
altRX costs $30 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between altRX and Nurx, the first difference is cost: altRX is $30 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. altRX leads our six-part score, 6.7 to 4.8. One of the two has an FDA warning letter on record, covered below.
altRX vs Nurx price
altRX is the cheaper way in: $149 a month against $179 a month at Nurx. That is $30 less each month (17% lower), or about $360 over a year of treatment.
Drug by drug: Semaglutide is cheaper at altRX ($149 a month vs $179 a month); tirzepatide is cheaper at Nurx ($179 a month vs $249 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, altRX prices compounded injections and brand-name pens, while Nurx prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, altRX is the only one of the two with a brand-name price.
Where each one treats patients
Neither altRX nor Nurx publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
altRX
Nurx
Range up to $299/mo
Range up to $299/mo
What each price covers
altRX's price also covers the clinician visit, the medication itself and shipping, which Nurx does not claim.
altRX is silent on lab work and coaching.
Nurx is silent on shipping, lab work and coaching.
That matters most for the drug: unless Nurx confirms otherwise, budget for medication on top of its listed price.
altRX
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Nurx
Covered by the monthly price
Medication
Charged on top
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, altRX scores 6.7 and Nurx 4.8 out of 10.
altRX is stronger on value (5.0 vs 3.0), user experience (8.0 vs 3.0) and support (7.0 vs 0.0).
Nurx is stronger on trust & safety (4.0 vs 3.5).
Effectiveness and accessibility are within half a point.
altRX
6.7/10
Nurx
4.8/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent altRX a warning letter dated June 8, 2026 (letter 728236), and it is still open.
Nurx has no FDA warning letter on record with us.
Features & Coverage
| Feature | altRX | Nurx |
|---|---|---|
| Starting Price | ✓$149/mo | $179/mo |
| Features | ✓8 features | 3 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About altRX
Compounded plans open at $149 for semaglutide and $249 for tirzepatide. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer.
Read our full altRX review →About Nurx
Nurx is an established women's telehealth brand running tiered GLP-1 weight loss programs.
Read our full Nurx review →Pros & Cons
altRX
What we like
- Tirzepatide costs $1249 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
Watch-outs
- Semaglutide costs $1149 a month, 16% above the $990 median for brand-name semaglutide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued altRX a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Nurx
What we like
- We found no FDA warning letters issued to Nurx
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Not included in the monthly price: medication, clinician visits
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
altRX wins this one, 6.7 to 4.8, above all for semaglutide from $1149/month. It also costs $30 less each month than Nurx.
Choose altRX if…
You want semaglutide from $1149/month and an opening price near $149 a month.
Choose Nurx if…
You want broader feature coverage and an opening price near $179 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →altRX vs Nurx: FAQ
Close alternatives to altRX and Nurx
- altRX vs Gala
- altRX vs Sprout Health
- altRX vs Aquivia Health
- altRX vs Vytora Health
- Nurx vs TrimRx
- Nurx vs Bodybuilding Health+
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.